BioNxt Solutions

Activities: Drug Delivery Dosage Forms

Trending Articles

  1. ProImmune Ltd introduces ProVE SL Self-Loading MHC Class I Monomers to improve T cell research flexibility ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers. The novel reagents for...
  2. Lilly partners with NVIDIA to build pharma’s most powerful AI supercomputer for faster drug discovery Eli Lilly has joined forces with NVIDIA to create the world’s most powerful pharmaceutical supercomputer, designed to accelerate AI-driven medicine discovery and...
  3. Mobile modular cleanrooms and biocontainment labs by Monmouth Scientific and IMeBIO Monmouth Scientific is proud to announce a strategic partnership with IMeBIO, a global leader in modular and mobile containment solutions
  4. Pistoia Alliance launches Phase 3 of CMC Process Ontology to bridge life sciences data gap and accelerate AI adoption Backed by major pharma companies, the initiative aims to standardise experimental and process data across R&D and manufacturing, enabling automation and AI-ready data...
  5. Jabil and Kymanox collaboration to deliver end-to-end development, regulatory and manufacturing solutions Jabil and Kymanox are partnering to combine their regulatory, technical, and manufacturing expertise to help life science companies streamline development and bring complex...

Related Content

Drug Delivery

BioNxt signs agreement to acquire novel solid oral drug dosage tech

"This coating system could significantly improve oral tablet and oral capsule drug delivery with more precise drug release and predictable dosing."
Subscribe now